R Evans1, K H Martin2, B S Moses1, W L Slone1, I Hare3, D Piktel1, P Thomas1, L F Gibson3. 1. Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, USA. 2. Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, USA; Department of Neurobiology and Anatomy, West Virginia University School of Medicine, USA. 3. Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, USA; Department of Microbiology, Immunology and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, USA.
Authors: Yuxing Zhao; Jonathan L Coloff; Emily C Ferguson; Sarah R Jacobs; Kai Cui; Jeffrey C Rathmell Journal: J Biol Chem Date: 2008-11-06 Impact factor: 5.157
Authors: Yordanos Tesfai; Jette Ford; Kim W Carter; Martin J Firth; Rebecca A O'Leary; Nicholas G Gottardo; Catherine Cole; Ursula R Kees Journal: Leuk Res Date: 2011-09-01 Impact factor: 3.156
Authors: Benjamin Boyerinas; Maya Zafrir; Ali E Yesilkanal; Trevor T Price; Elizabeth M Hyjek; Dorothy A Sipkins Journal: Blood Date: 2013-04-15 Impact factor: 22.113
Authors: Stephanie L Rellick; Gangqing Hu; Debra Piktel; Karen H Martin; Werner J Geldenhuys; Rajesh R Nair; Laura F Gibson Journal: Sci Rep Date: 2021-08-04 Impact factor: 4.996